Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
03 2019
Historique:
received: 13 07 2018
revised: 14 10 2018
accepted: 23 10 2018
pubmed: 12 12 2018
medline: 20 11 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

To determine the temporal trends in the epidemiology of acute disseminated encephalomyelitis (ADEM) and hospitalization outcomes in the US from 2006 through 2014. Pediatric (≤18 years of age) hospitalizations with ADEM discharge diagnosis were identified from the National (Nationwide) Inpatient Sample (NIS) for years 2006 through 2014. Trends in the incidence of ADEM with respect to age, sex, race, and region were examined. Outcomes of ADEM in terms of mortality, length of stay (LOS), cost of hospitalization, and seasonal variation were analyzed. NIS includes sampling weight. These weights were used to generate national estimates. P value  of < .05 was considered significant. Overall incidence of ADEM associated pediatric hospitalizations from 2006 through 2014 was 0.5 per 100 000 population. Between 2006 through 2008 and 2012 through 2014, the incidence of ADEM increased from 0.4 to 0.6 per 100 000 (P-trend <.001). Black and Hispanic children had a significantly increased incidence of ADEM during the study period (0.2-0.5 per 100 000 population). There was no sex preponderance and 67% of ADEM hospitalizations were in patients <9 years old. From 2006 through 2008 to 2012 through 2014 (1.1%-1.5%; P-trend 0.07) and median LOS (4.8-5.5 days; P In this large nationwide cohort of ADEM hospitalizations, the incidence of ADEM increased during the study period. Mortality and LOS have remained stable over time, but inflation adjusted cost of hospitalizations increased.

Identifiants

pubmed: 30528761
pii: S0022-3476(18)31551-8
doi: 10.1016/j.jpeds.2018.10.044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-32.e1

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Parth Bhatt (P)

Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, TX. Electronic address: 5.parthbhatt@gmail.com.

Leonita Bray (L)

Department of Pediatrics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Sneha Raju (S)

Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, TX.

Fredrick Dapaah-Siakwan (F)

Department of Pediatrics, University of Miami, Coral Gables, FL.

Achint Patel (A)

Department of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY.

Riddhi Chaudhari (R)

Department of Pediatrics, University of Connecticut, Farmington, CT.

Keyur Donda (K)

Department of Pediatrics, University of Miami, Coral Gables, FL.

Neel S Bhatt (NS)

Department of Pediatrics, Division of Hematology/ Oncology/ BMT, Medical College of Wisconsin, Milwaukee, WI.

Mihir Dave (M)

Department of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY.

Vijay Gandhi Linga (VG)

Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, TX.

Anusha Lekshminarayanan (A)

Department of Internal Medicine, Mercy Health, Cincinnati, OH.

Samir V Patel (SV)

Department of Internal Medicine, Sparks Health Systems, Fort Smith, AR.

Zeenia C Billimoria (ZC)

Department of Pediatrics, University of Washington; Seattle, WA.

Samuel Zuckerman (S)

Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, TX.

Priyank Yagnik (P)

Department of Pediatrics, University of Kansas School of Medicine, Wichita, KS.

Dinesh Singh (D)

Department of Pediatrics, Tulane University, New Orleans, LA; Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH